Will GW’s multibillion-dollar sale ‘open floodgates’ to pharma-cannabis deal-making?
Jazz Pharmaceuticals’ planned $7.2 billion takeover of United Kingdom-based GW Pharmaceuticals could kick off a wave of deal-making between pharma…
Jazz Pharmaceuticals’ planned $7.2 billion takeover of United Kingdom-based GW Pharmaceuticals could kick off a wave of deal-making between pharma…
Canadian cannabis producer Cronos Group reported improved revenue for its latest quarter, but a bottom line that remains in the…
Wildfires in the West have devastated a number of marijuana farms in Oregon, Washington state and California, while an early…
Toronto-based cannabis company Cronos Group reported an adjusted operating loss of $31.3 million for its second quarter, along with $40…
Toronto-based cannabis firm Cronos Group reported an adjusted operating loss of $31.3 million for its second quarter, along with $40…
A lawsuit filed in the Court of Queens’ Bench in Alberta is making some pretty heavy allegations and naming a…
South Korea’s sovereign wealth fund bought up three Canadian cannabis stocks as they dipped to 52-week lows in the first…
South Korea’s sovereign wealth fund bought up three Canadian cannabis stocks as they dipped to 52-week lows in the first…
Canadian cannabis producer Cronos Group reported $165,000 in net revenue from customers outside Canada and the United States in its…
PRESS RELEASE Completed Audit Committee Review and Restated Certain 2019 Unaudited Interim Financial Statements Expanded Canadian distribution to new provinces…